Filter announcements
Loading...
Incorporated in 1989, Venus RemediesLtd is a research based pharmaceutical company and an injectable manufacturer
Venus Remedies has launched a special communication campaign across major social media channels. The initiative aims to inform shareholders about the newly opened special window for re-lodging transfer requests for physical shares, helping investors easily navigate the process and resolve pending paper share transfers.
Company uses social media (Instagram, Facebook, LinkedIn, X) to urge shareholders to update KYC details. This proactive communication aims to enhance shareholder data accuracy and regulatory compliance.
Venus Remedies announced a special window for shareholders to re-lodge transfer requests for physical shares. This simplifies the process for investors. Details are available on the company's social media platforms.
Venus Remedies is using social media (Instagram, Facebook, LinkedIn, X) to prompt shareholders to update their KYC details. This move enhances compliance and improves shareholder communication.
Venus Remedies (VENUSREM) renewed crucial R&D recognition, validating its commitment to antimicrobial resistance research. This supports innovative drug development, including USFDA-designated VRP-034, signaling a strong future pipeline.